Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Acasti Pharma Inc ACST

Healthcare
Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the... see more

NDAQ:ACST - Post Discussion

Acasti Pharma Inc > ACST to Face Investors
View:
Post by ReneSamuelsJr on May 21, 2019 11:57pm

ACST to Face Investors

ICYMI

https://bit.ly/2YA7gp4
Comment by Stormdog01 on May 22, 2019 9:01am
Once again they use any kind of BS presentation news to hide the Nasdaq de-listing notice they are required to publish for having the stock below 1.00$USD for 30 days.
Comment by Canadian_101 on May 22, 2019 3:03pm
It did seem odd to me that it was announced this way, seemed like it was a "OH by the way Moment" , I wouldn"t worry to much about it, last time the stock jumped up pretty quickly after they had to annouce it was below a buck, stay long and prosper!!
Comment by TechOne on May 22, 2019 4:28pm
They have 180 days, or 6 months to correct this..  By that time, there will be few more catalysts along the way and one of the two Trial Groups will be ready to report the results..  And well before that, speculators will be clamouring for some action.. So Not an issue.. If some one is worried that share price is trading a dime lower then the $1 threshold, they don't see the big ...more  
Acasti Pharma Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities